Coccidioidomycosis in Patients Treated With Ruxolitinib.
Clicks: 160
ID: 108013
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
4.5
/100
15 views
15 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
We report 8 cases of coccidioidomycosis associated with ruxolitinib treatment. Among 135 patients living in the coccidioidal-endemic region receiving ruxolitinib, 5 cases were diagnosed after starting and 4 had extrathoracic dissemination. Periodic serological screening while on ruxolitinib is warranted for patients residing in the coccidioidal-endemic region.
| Reference Key |
kusne2020coccidioidomycosisopen
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Kusne, Yael;Kimes, Kathryn E;Feller, Fionna F;Patron, Roberto;Banacloche, Juan Gea;Blair, Janis E;Vikram, Holenarasipur R;Ampel, Neil M; |
| Journal | Open forum infectious diseases |
| Year | 2020 |
| DOI |
10.1093/ofid/ofaa167
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.